Compare Stocks: PRCT, IRTC, PLSE, and TMDX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRTC iRhythm Technologies	$102.60 -2.3%	$117.74	$100.70 ▼ $212.00	$3.46B	1.45	516,369 shs	668,310 shs
PLSE Pulse Biosciences	$49.98 +1.8%	$48.59	$12.56 ▼ $58.90	$3.48B	1.57	570,045 shs	315,582 shs
PRCT PROCEPT BioRobotics	$17.90 -0.1%	$19.95	$16.67 ▼ $38.11	$1.03B	0.92	1.39 million shs	1.18 million shs
TMDX TransMedics Group	$79.00 -2.6%	$85.98	$60.10 ▼ $156.00	$2.73B	1.94	783,153 shs	949,379 shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRTC iRhythm Technologies	-2.28%	-7.61%	-16.07%	-11.65%	-42.68%
PLSE Pulse Biosciences	+1.81%	+0.30%	+2.44%	+90.11%	+150.65%
PRCT PROCEPT BioRobotics	-0.06%	+5.17%	-16.16%	-14.31%	-48.49%
TMDX TransMedics Group	-2.55%	+0.46%	-10.50%	+10.91%	-33.08%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRTC iRhythm Technologies	$102.60 -2.3%	$117.74	$100.70 ▼ $212.00	$3.46B	1.45	516,369 shs	668,310 shs
PLSE Pulse Biosciences	$49.98 +1.8%	$48.59	$12.56 ▼ $58.90	$3.48B	1.57	570,045 shs	315,582 shs
PRCT PROCEPT BioRobotics	$17.90 -0.1%	$19.95	$16.67 ▼ $38.11	$1.03B	0.92	1.39 million shs	1.18 million shs
TMDX TransMedics Group	$79.00 -2.6%	$85.98	$60.10 ▼ $156.00	$2.73B	1.94	783,153 shs	949,379 shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRTC iRhythm Technologies	-2.28%	-7.61%	-16.07%	-11.65%	-42.68%
PLSE Pulse Biosciences	+1.81%	+0.30%	+2.44%	+90.11%	+150.65%
PRCT PROCEPT BioRobotics	-0.06%	+5.17%	-16.16%	-14.31%	-48.49%
TMDX TransMedics Group	-2.55%	+0.46%	-10.50%	+10.91%	-33.08%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IRTC iRhythm Technologies	2.94	Moderate Buy	$178.79	74.26% Upside
PLSE Pulse Biosciences	2.86	Moderate Buy	$53.20	6.44% Upside
PRCT PROCEPT BioRobotics	2.25	Hold	$25.50	42.46% Upside
TMDX TransMedics Group	2.38	Hold	$121.00	53.16% Upside

Current Analyst Ratings Breakdown

Latest PRCT, IRTC, PLSE, and TMDX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/7/2026	TMDX TransMedics Group	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$120.00
10/6/2026	PRCT PROCEPT BioRobotics	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$30.00
10/6/2026	PLSE Pulse Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$43.00 ➝ $58.00
10/6/2026	IRTC iRhythm Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$168.00 ➝ $150.00
10/5/2026	IRTC iRhythm Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$192.00 ➝ $194.00
9/23/2026	PLSE Pulse Biosciences	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$70.00
9/23/2026	PLSE Pulse Biosciences	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$70.00
9/14/2026	IRTC iRhythm Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/11/2026	TMDX TransMedics Group	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/9/2026	PRCT PROCEPT BioRobotics	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform
9/9/2026	PLSE Pulse Biosciences	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 10/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IRTC iRhythm Technologies	$825.34M	4.10	N/A	N/A	$4.74 per share	21.65
PLSE Pulse Biosciences	$350K	10,110.24	N/A	N/A	$1.19 per share	42.00
PRCT PROCEPT BioRobotics	$308.05M	3.33	N/A	N/A	$6.55 per share	2.73
TMDX TransMedics Group	$605.49M	4.51	$3.83 per share	20.64	$13.79 per share	5.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IRTC iRhythm Technologies	-$44.55M	-$0.43	N/A	70.76	N/A	-1.69%	10.11%	1.53%	10/29/2026 (Estimated)
PLSE Pulse Biosciences	-$72.78M	-$1.18	N/A	N/A	N/A	-6,755.78%	-94.42%	-79.96%	11/4/2026 (Estimated)
PRCT PROCEPT BioRobotics	-$95.57M	-$1.94	N/A	N/A	N/A	-32.53%	-30.62%	-22.10%	11/3/2026 (Estimated)
TMDX TransMedics Group	$190.29M	$3.89	20.31	34.96	1.11	22.69%	15.88%	5.95%	11/4/2026 (Estimated)

Latest PRCT, IRTC, PLSE, and TMDX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	PLSE Pulse Biosciences	-$0.35	N/A	N/A	N/A	$0.61 million	N/A
11/4/2026	Q3 2026	TMDX TransMedics Group	$0.2976	N/A	N/A	N/A	$177.45 million	N/A
11/3/2026	Q3 2026	PRCT PROCEPT BioRobotics	-$0.3902	N/A	N/A	N/A	$100.84 million	N/A
10/29/2026	Q3 2026	IRTC iRhythm Technologies	$0.0230	N/A	N/A	N/A	$222.26 million	N/A
8/6/2026	Q2 2026	IRTC iRhythm Technologies	-$0.04	$0.58	+$0.62	-$0.01	$219.30 million	$224.17 million
8/6/2026	Q2 2026	PLSE Pulse Biosciences	-$0.2933	-$0.36	-$0.0667	-$0.36	$0.53 million	$0.43 million
8/4/2026	Q2 2026	PRCT PROCEPT BioRobotics	-$0.4619	-$0.47	-$0.0081	-$0.47	$92.77 million	$94.50 million
8/4/2026	Q2 2026	TMDX TransMedics Group	$0.4955	$0.44	-$0.0555	$0.41	$184.00 million	$189.95 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
TMDX TransMedics Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IRTC iRhythm Technologies	3.50	3.86	3.74
PLSE Pulse Biosciences	N/A	9.63	9.61
PRCT PROCEPT BioRobotics	0.15	6.55	5.35
TMDX TransMedics Group	1.62	6.62	6.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IRTC iRhythm Technologies	N/A
PLSE Pulse Biosciences	76.95%
PRCT PROCEPT BioRobotics	89.46%
TMDX TransMedics Group	99.67%

Insider Ownership

Company	Insider Ownership
IRTC iRhythm Technologies	0.98%
PLSE Pulse Biosciences	74.00%
PRCT PROCEPT BioRobotics	4.00%
TMDX TransMedics Group	6.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IRTC iRhythm Technologies	2,400	32.96 million	32.64 million	Optionable
PLSE Pulse Biosciences	116	70.80 million	18.41 million	Optionable
PRCT PROCEPT BioRobotics	888	57.27 million	54.98 million	Optionable
TMDX TransMedics Group	898	34.56 million	32.18 million	Optionable

PRCT, IRTC, PLSE, and TMDX Headlines

Recent News About These Companies

Barclays Initiates Coverage on TransMedics Group (NASDAQ:TMDX)

October 9 at 2:07 AM | americanbankingnews.com

Barclays initiates coverage of TransMedics Group at overweight

October 8 at 7:36 PM | msn.com

TransMedics Group consensus price target rises 10.91% to MX$1,984.96

October 8 at 7:36 PM | msn.com

41,109 TransMedics Group, Inc. $TMDX Shares Sold by Zevenbergen Capital Investments LLC

October 8 at 7:35 PM | marketbeat.com

TransMedics Group stock gets USD 120.00 target from Barclays

October 8 at 2:35 PM | ad-hoc-news.deA

TransMedics Group (NASDAQ:TMDX) Shares Climb 4.2% - Time to Buy?

October 7 at 2:20 PM | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Now Covered by Analysts at Barclays

October 7 at 9:05 AM | marketbeat.com

TransMedics Group, Inc. $TMDX Shares Purchased by Congress Asset Management Co.

October 7 at 3:04 AM | marketbeat.com

TransMedics Group, Inc. (NASDAQ:TMDX) Stock Rated "Hold" by Sell-Side Analysts

October 5, 2026 | americanbankingnews.com

TransMedics Group, Inc. (NASDAQ:TMDX) Stock Has Average Price Target of $121.10 According to Brokerages

October 5, 2026 | marketbeat.com

TransMedics Group (TMDX) Stock Looks Below Fair Value On Earnings

October 4, 2026 | finance.yahoo.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

October 3, 2026 | theglobeandmail.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

October 3, 2026 | theglobeandmail.com

TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative Holds

October 2, 2026 | finance.yahoo.com

TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?

September 29, 2026 | fool.com

TransMedics (TMDX)

September 28, 2026 | es.investing.com

TransMedics Offers An Attractive Entry Point, With Upside Potential Outweighing Risks

September 26, 2026 | seekingalpha.com

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

September 26, 2026 | prnewswire.com

Investors Purchase Large Volume of TransMedics Group Put Options (NASDAQ:TMDX)

September 25, 2026 | marketbeat.com

Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX)

September 23, 2026 | theglobeandmail.com

【TMDX】TransMedics Group

September 19, 2026 | note.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT, IRTC, PLSE, and TMDX Company Descriptions

iRhythm Technologies NASDAQ:IRTC

$102.60 -2.39 (-2.28%)

Closing price 10/8/2026 04:00 PM Eastern

Extended Trading

$103.01 +0.41 (+0.40%)

As of 07:21 AM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Pulse Biosciences NASDAQ:PLSE

$49.98 +0.89 (+1.81%)

Closing price 10/8/2026 04:00 PM Eastern

Extended Trading

$49.23 -0.75 (-1.51%)

As of 07:03 AM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

PROCEPT BioRobotics NASDAQ:PRCT

$17.90 -0.01 (-0.06%)

Closing price 10/8/2026 04:00 PM Eastern

Extended Trading

$17.96 +0.06 (+0.34%)

As of 07:19 AM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

TransMedics Group NASDAQ:TMDX

$79.00 -2.07 (-2.55%)

Closing price 10/8/2026 04:00 PM Eastern

Extended Trading

$78.65 -0.35 (-0.44%)

As of 07:01 AM Eastern

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PRCT, IRTC, PLSE, and TMDX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PRCT, IRTC, PLSE, and TMDX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PRCT, IRTC, PLSE, and TMDX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT, IRTC, PLSE, and TMDX Company Descriptions

iRhythm Technologies NASDAQ:IRTC

Pulse Biosciences NASDAQ:PLSE

PROCEPT BioRobotics NASDAQ:PRCT

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PRCT, IRTC, PLSE, and TMDX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PRCT, IRTC, PLSE, and TMDX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PRCT, IRTC, PLSE, and TMDX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT, IRTC, PLSE, and TMDX Company Descriptions

iRhythm Technologies NASDAQ:IRTC

Pulse Biosciences NASDAQ:PLSE

PROCEPT BioRobotics NASDAQ:PRCT

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools